Subscription AgreementSubscription Agreement • January 6th, 2021 • PAVmed Inc. • Surgical & medical instruments & apparatus
This subscription agreement (this “Subscription”) is dated as of the date set forth on the signature page hereto, by and between the investor identified on the signature page hereto (the “Investor”) and PAVmed Inc., a Delaware corporation (the “Company”), whereby the parties agree as follows:
Lishan Aklog, M.D. Chairman & Chief Executive Officer PAVmed Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Dear Dr. Aklog:PAVmed Inc. • January 6th, 2021 • Surgical & medical instruments & apparatus • New York
This letter (the “Agreement”) constitutes the agreement between Maxim Group LLC (“Maxim” or the “Placement Agent”) and PAVmed Inc. (the “Company”), pursuant to which Maxim shall serve as the lead exclusive placement agent for the Company, on a “reasonable best efforts” basis, in connection with the proposed placement (the “Placement”) of registered shares (the “Shares” or the “Securities”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The terms of the Placement and the Securities shall be mutually agreed upon by the Company and the purchasers (each, a “Purchaser” and collectively, the “Purchasers”) and nothing herein constitutes that the Placement Agent would have the power or authority to bind the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the documents executed and delivered by the Company and the Purchasers in connection with the Placement shall be collectively refe
